台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    66.2
  • 漲跌
    ▼0.2
  • 漲幅
    -0.30%
  • 成交量
    169
  • 產業
    上櫃 生技醫療類股
  • 70人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-台中銀-豐原 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台中銀-豐原 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2700.002.166.4566.20-2.1478-0.44%
2025/02/26266.4500.0066.4024900.41%
2025/02/21169.70769.5067.80-6508-1.18%
2025/02/208.166.27564.5671.003.14970.62%
2025/02/19564.3000.0065.5054901.02%
2025/02/1700.00562.2062.20-5521-0.96%
2025/02/14562.6200.0063.0055430.92%
2025/02/1300.00563.0462.80-5574-0.87%
2025/02/12561.90562.8461.9005850.00%
2025/02/11561.7800.0064.0055940.84%
2025/02/0500.00560.7060.70-5605-0.83%
2025/01/1700.00160.0058.60-1616-0.16%
2025/01/1600.00461.1061.40-4613-0.65%
2025/01/1400.00163.9062.90-1621-0.16%
2025/01/10164.8000.0065.4016240.16%
2025/01/0600.00165.0065.10-1623-0.16%
2025/01/0300.00263.4062.60-2631-0.32%
2025/01/0200.00164.2064.20-1643-0.16%
2024/12/31163.90163.3064.3006690.00%
2024/12/30166.10165.7066.7006920.00%
2024/12/27362.6000.0063.3036970.43%
2024/12/26567.80669.1566.60-1692-0.14%
2024/12/25474.13275.9574.0026830.29%
2024/12/24172.70372.4073.00-2677-0.30%
2024/12/23366.2000.0066.4036800.44%
2024/12/20261.1000.0060.4026840.29%
2024/12/19663.65163.2062.7056950.72%
2024/12/18160.80257.6060.90-1678-0.15%
2024/12/1200.00152.7054.90-1678-0.15%
2024/12/11155.0000.0054.9016660.15%
2024/12/10261.55264.2060.9006480.00%
2024/12/09261.9000.0062.0026460.31%
2024/12/0600.00266.1564.30-2651-0.31%
2024/12/05165.5000.0065.5016550.15%
2024/12/04167.2000.0067.0016550.15%
2024/12/0300.00166.8067.80-1662-0.15%
2024/12/02167.0000.0066.6016630.15%
2024/11/29167.40164.5067.9006710.00%
2024/11/28165.20165.3064.8006720.00%
2024/11/22170.90371.6373.00-2672-0.30%
2024/11/21168.00167.5068.0006620.00%
2024/11/19168.60267.7567.40-1667-0.15%
2024/11/18268.9000.0067.0026760.30%
2024/11/15266.50167.7066.0016780.15%
2024/11/14169.00266.7569.00-1670-0.15%
2024/11/13263.2000.0064.0026520.31%
2024/11/1200.00564.7070.00-5632-0.79%
2024/11/06587.0000.0085.2056340.79%
2024/10/1700.003119.00122.00-3779-0.38%
2024/10/1400.003115.50121.00-3817-0.37%
2024/10/0700.005108.50116.50-5830-0.60%
2024/10/046102.7500.00106.5068130.74%
2024/10/01197.2000.0097.2017870.13%
2024/09/302108.0010108.00108.00-8777-1.03%
2024/09/274124.7500.00120.0047960.50%
2024/09/261133.0000.00133.0017850.13%
2024/09/161174.0000.00175.5017800.13%
2024/09/052205.5000.00206.0027970.25%
2024/08/261226.0000.00226.0017900.13%
2024/08/2100.001218.50225.00-1802-0.12%
2024/08/201217.0000.00216.0018060.12%
2024/08/1500.006190.58191.50-6827-0.73%
2024/08/125204.505198.00198.0008350.00%
2024/08/091202.5000.00203.5018240.12%
2024/08/085187.002186.00187.0037940.38%
2024/08/072178.7500.00180.0027810.26%
2024/08/0100.004173.75175.50-4732-0.55%
2024/07/314161.3800.00161.0047270.55%
2024/07/291147.000141.50141.5017080.14%
2024/07/225164.0000.00164.0056670.75%
2024/07/1800.005188.00196.50-5611-0.82%
2024/07/1710175.2500.00191.00105891.70%
2024/07/1200.001158.00162.00-1544-0.18%
2024/07/0900.002138.50139.00-2499-0.40%
2024/07/085133.5000.00138.5054931.01%
2024/07/032130.0000.00124.5024740.42%
2024/07/015135.0000.00137.5054351.15%
2024/06/04095.4000.0096.0003160.00%
2024/05/2800.000.199.50100.00-0.1312-0.03%
2024/04/1200.00166.5066.00-1252-0.40%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音